🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Apex Biotechnology Corp. (TPE:1733)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
28.00
-0.70 (-2.44%)
Nov 20, 2026, 1:30 PM CST

Apex Biotechnology Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
518.41567.09532.69382.05331.71555.33
Trading Asset Securities
71.677.2866.161.8765.8369.72
Cash & Short-Term Investments
590.02644.37598.78443.91397.53625.05
Cash Growth
5.15%7.61%34.89%11.67%-36.40%-24.05%
Accounts Receivable
417.76437.8346.64288.39486.77474.41
Other Receivables
14.219.818.085.7210.1213.97
Receivables
431.97447.61354.72294.11496.89488.38
Inventory
663.52561.83662.49747.71739.25628.59
Prepaid Expenses
-18.8218.7818.511911.06
Other Current Assets
23.750.988.292.41.816.78
Total Current Assets
1,7091,6741,6431,5071,6541,760
Property, Plant & Equipment
650.32652.64695.81720.59766.08794.12
Long-Term Investments
6.2-----
Other Intangible Assets
31.5935.7139.644.2269.14106.48
Long-Term Deferred Tax Assets
8.2112.89.244.243.620.43
Other Long-Term Assets
34.1841.0632.2321.3221.389.58
Total Assets
2,4402,4162,4202,2972,5152,670

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
246.32231.7239.03156.22289.69343.89
Accrued Expenses
-154.93142.25133.43150.55148.07
Short-Term Debt
---3050150
Current Portion of Leases
6.37.699.037.28.016.88
Current Income Taxes Payable
17.525.8824.5246.2436.9240.12
Current Unearned Revenue
12.837.2358.286.629.0493.06
Other Current Liabilities
164.364.624.683.676.353.87
Total Current Liabilities
447.31432.05477.78383.35570.55785.89
Long-Term Leases
110.76101.98113.93116.2122.67127.66
Long-Term Deferred Tax Liabilities
3.6410.823.540.043.12.88
Other Long-Term Liabilities
0.490.470.470.480.490.48
Total Liabilities
562.2545.32595.7500.07696.81916.91

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
999.5999.5999.5999.5999.5999.5
Additional Paid-In Capital
---68.3768.3768.37
Retained Earnings
796.83791.23744.06718.87739.95682.34
Comprehensive Income & Other
80.0878.9880.049.699.512.52
Total Common Equity
1,8761,8701,8241,7961,8171,753
Minority Interest
1.150.770.630.50.570.82
Shareholders' Equity
1,8781,8701,8241,7971,8181,754
Total Liabilities & Equity
2,4402,4162,4202,2972,5152,670

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
117.06109.67122.96153.4180.68284.55
Net Cash (Debt)
472.96534.69475.83290.52216.85340.5
Net Cash Growth
5.19%12.37%63.79%33.97%-36.31%10.11%
Net Cash Per Share
4.725.324.742.902.153.22
Filing Date Shares Outstanding
102.7899.9599.9599.9599.9599.95
Total Common Shares Outstanding
102.7899.9599.9599.9599.9599.95
Working Capital
1,2621,2421,1651,1231,084973.97
Book Value Per Share
18.2618.7118.2517.9718.1817.54
Tangible Book Value
1,8451,8341,7841,7521,7481,646
Tangible Book Value Per Share
17.9518.3517.8517.5317.4916.47
Land
-261.68261.68261.68261.68261.68
Buildings
-605.02605.02604.13604.13601.96
Machinery
-816.08806.49789.71777.35754.25